Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes

Emergence of protein kinase CK2 as a key target in cancer therapy

(2010) Janeen H. Trembley et al.   BIOFACTORS

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

(2010) A. Siddiqui-Jain et al.   CANCER RESEARCH

Casein Kinase II: An attractive target for anti-cancer drug design

(2010) Ismail Muhamad Hanif et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis

(2009) Mauro Salvi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The Regulatory β Subunit of Protein Kinase CK2 Contributes to the Recognition of the Substrate Consensus Sequence. A Study with an eIF2β-Derived Peptide†

(2008) Giorgia Poletto et al.   BIOCHEMISTRY

Protein Kinase CK2 in Human Diseases

(2008) Barbara Guerra et al.   CURRENT MEDICINAL CHEMISTRY

Gene targeting of CK2 catalytic subunits

(2008) David C. Seldin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Protein kinase CK2 as a druggable target

(2008) Stefania Sarno et al.   Molecular BioSystems

Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2

(2007) James S. Duncan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS